Intra-Cellular Therapies
ApprovedOur mission is to deliver innovative treatments to improve the lives of individuals with neuropsychiatric, neurologic, and other disorders to reduce the burden on patients and their caregivers.
Founded
2002
Focus
Small Molecules
About
Our mission is to deliver innovative treatments to improve the lives of individuals with neuropsychiatric, neurologic, and other disorders to reduce the burden on patients and their caregivers.
Funding History
6Total raised: $275M
PIPE$100MUndisclosedJun 15, 2019
IPO$75MUndisclosedAug 7, 2013
Series D$40MUndisclosedJun 15, 2010
Series C$30MUndisclosedJun 15, 2007
Company Info
TypePrivate
Founded2002
LocationNew York, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile